Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MGEN OTCMKTS:POTN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMGENMiragen Therapeutics$14.47+3.7%$17.69$4.66▼$34.05$56.55M1.66134,027 shs4.59 million shsPOTNUnited Treatment Centers$0.00$0.00▼$0.00N/AN/AN/A1 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMGENMiragen Therapeutics0.00%0.00%+4.10%-50.39%+20.28%POTNUnited Treatment Centers0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMGENMiragen Therapeutics$14.47+3.7%$17.69$4.66▼$34.05$56.55M1.66134,027 shs4.59 million shsPOTNUnited Treatment Centers$0.00$0.00▼$0.00N/AN/AN/A1 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMGENMiragen Therapeutics0.00%0.00%+4.10%-50.39%+20.28%POTNUnited Treatment Centers0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMGENMiragen Therapeutics 0.00N/AN/AN/APOTNUnited Treatment Centers 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMGENMiragen Therapeutics$4.46M12.68N/AN/A$6.78 per share2.13POTNUnited Treatment CentersN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMGENMiragen Therapeutics-$41.87M-$20.09N/AN/AN/A-1,393.50%-141.66%-88.74%N/APOTNUnited Treatment CentersN/AN/AN/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMGENMiragen TherapeuticsN/AN/AN/AN/AN/APOTNUnited Treatment CentersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMGENMiragen Therapeutics0.204.234.23POTNUnited Treatment CentersN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMGENMiragen TherapeuticsN/APOTNUnited Treatment CentersN/AInsider OwnershipCompanyInsider OwnershipMGENMiragen Therapeutics1.10%POTNUnited Treatment Centers0.22%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMGENMiragen Therapeutics453.91 millionN/ANot OptionablePOTNUnited Treatment Centers13N/AN/ANot OptionableMGEN and POTN HeadlinesRecent News About These CompaniesA reader's guide for "Wellness: A novel," Oprah's book club pickSeptember 19, 2023 | msn.comNordstrom Gets the Diamond-Hands TreatmentFebruary 3, 2023 | wsj.comHead to Head Analysis: Charlie's (OTCMKTS:CHUC) & PotNetwork (OTCMKTS:POTN) - ETF Daily NewsNovember 27, 2022 | news.google.comNPotNetwork (OTCMKTS:POTN) vs. Mind Medicine (MindMed) (NASDAQ:MNMD) Critical Review - ETF Daily NewsNovember 12, 2022 | news.google.comNCBD Gummies Market Size to Hit USD 13.39 Billion by 2030; Upsurge in Demand for CBD-based Products to Bolster Growth: The Brainy Insights - Yahoo FinanceNovember 10, 2022 | news.google.comNCBD Gummies Market Size to Hit USD 13.39 Billion by 2030; Upsurge in Demand for CBD-based Products to Bolster Growth: The Brainy Insights - GlobeNewswireNovember 9, 2022 | news.google.comNBest HHC Gummies For Sale In 2022: Top 4 Hemp Brands That Sell HHC Products - KHTS RadioSeptember 13, 2022 | hometownstation.comHDIAMOND WELLNESS HOLDINGS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - Marketscreener.comAugust 5, 2022 | marketscreener.comMAltcoins: Potcoin (POT) - What Is It? - A Deeper Look Into the Potcoin (POT) Platform - https://bitnewstoday.com/August 4, 2022 | bitnewstoday.comBWhat Differentiates Proof-of-Stakes and Proof-of-Time Consensus Mechanism? - The Coin RepublicJuly 26, 2022 | thecoinrepublic.comTGlobal Kid's Camera Market 2022 Industry Scenario and Demand – Vtech, Oaxis, Fujifilm, SJCAM – Indian Defence News - Indian Defence NewsJune 30, 2022 | indiandefencenews.infoIGlobal Pet CBD (cannabidiol) Market 2022 by Top Players and Vendors: ,Canna-Pet ,Choom Holdings ,Receptra Naturals ,Curaleaf ,Trulieve Cannabis ,Pure Spectrum ,Cannabis Strategies Acquisition ,Pet Releaf ,Diamond CBD ,PotNetwork Holdings ,Kat&# - Indian Defence NewsJune 30, 2022 | indiandefencenews.infoIGlobal Pet CBD (cannabidiol) Market 2022 by Top Players: ,Canna-Pet ,Choom Holdings ,Receptra Naturals ,Curaleaf ,Trulieve Cannabis ,Pure Spectrum ,Cannabis Strategies Acquisition ,Pet Releaf ,Diamond CBD ,PotNetwork Holdings ,Kat's Naturals , - mbu timelineJune 6, 2022 | mbutimeline.comMPet CBD(cannabidiol) Market Trend And Forecast| Key Players – Canna-Pet, PotNetwork Holdings, Choom Holdings, Curaleaf, Trulieve Cannabis – Industrial IT - Industrial ITMay 30, 2022 | industrialit.com.auIPOTNETWORK HOLDINGS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K) - Marketscreener.comMay 27, 2022 | marketscreener.comMPotNetwork Holdings, Inc. (POTN) Will Change Its Name to "Diamond Wellness Holdings, Inc." - Be - BenzingaMay 26, 2022 | benzinga.comPotNetwork Holdings, Inc. (POTN) Will Change Its Name to "Diamond Wellness Holdings, Inc."May 26, 2022 | finance.yahoo.comForm DEF 14C PotNetwork Holdings, For: May 25 - StreetInsider.comMay 25, 2022 | streetinsider.comPet CBD(cannabidiol) Market by 2029 | Canna-Pet, Choom Holdings, Receptra Naturals – SMU Daily Mustang - SMU Daily MustangMay 12, 2022 | smudailymustang.comSBest THC Gummies: Top 5 Weed Brands For Buying THC Edibles & Marijuana Gummies In 2022 - The Daily WorldMay 10, 2022 | thedailyworld.comTNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMGEN and POTN Company DescriptionsMiragen Therapeutics NASDAQ:MGENMiragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high-unmet medical need. Its four lead product candidates include cobomarsen, an inhibitor of miR-155 for treating various blood cancers, such as cutaneous T-cell lymphoma, adult T-cell lymphoma/leukemia, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia; Remlarsen, a replacement for miR-29, a microRNA that is found at abnormally low levels in various pathological fibrotic conditions, including cutaneous and ocular fibrosis, which is in Phase II clinical trial; MRG-229, which is in preclinical trial for the treatment of idiopathic pulmonary fibrosis; and MRG- 110, an inhibitor of miR-92, a microRNA expressed in endothelial cells, which has completed two Phase I clinical trial for the treatment of heart failure, wound healing, and other ischemic disease in the United States and Japan. Miragen Therapeutics, Inc. was founded in 2006 and is based in Boulder, Colorado.United Treatment Centers OTCMKTS:POTNDiamond Wellness Holdings Inc., through its subsidiaries, engages in the development and sale of hemp-derived cannabidiol (CBD) oil products. It offers flavored and unflavored oils; vaping pens and additives; edibles, such as chewable gummies and lollipops; capsules; beverage energy/relaxation shots; topical application creams in various concentrations; dog and cat wellness products in various dosages and delivery formats; skin care, bath, and body products; and hemp flowers. The company provides its products under various brands, including Diamond CBD, Chill, Relax, MediPets, and Meds BioTech, as well as various other brands. It sells its products through distributors and resellers, as well as through its Website. The company was formerly known as PotNetwork Holdings, Inc. Diamond Wellness Holdings Inc. is based in Fort Lauderdale, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound’s Bottom Is In—Inflection and 50% Upside Ahead? Rocket Lab Posts Record Q1 Revenue, Raises Q2 Guidance Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus AppLovin Pops After Earnings With Growth Catalysts in Sight Dutch Bros Q1 Earnings: The Newest Starbucks Rival Faces Its First Big Reality Check The AI Fear Around Datadog Stock May Have Been Completely Wrong Amprius Technologies Ups the Voltage on Forward Outlook Why Lam Research Still Looks Like a Buy After a 300% Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
